A prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells

Jingen Zhu, Pan Tao, Marthandan Mahalingam, Jian Sha, Paul Kilgore, Ashok Chopra, Venigalla Rao

Research output: Contribution to journalArticle

Abstract

Development of safe and efficient nanoscale vehicles that can deliver large molecular cargos into human cells could transform future human therapies and personalized medicine. Here, we design a hybrid viral vector composed of a prokaryotic virus (bacteriophage T4) and a eukaryotic virus [adeno-associated virus (AAV)]. The small 25-nm AAV is attached to the large 120 nm × 86 nm T4 head through avidin-biotin cross-bridges using the phage decoration proteins Soc and Hoc. AAV “piggy-backed” on T4 capsid, by virtue of its natural ability to enter human cells acted as an efficient “driver,” delivering the largest payloads of foreign DNA (up to 170 kb) and protein (up to 1025 molecules) reported to date, and elicited robust immune responses in mice against flu and plague pathogens and conferred complete protection against lethal pneumonic plague challenge. The T4-AAV represents a unique platform for assembly of natural building blocks into potential therapeutics against genetic and infectious diseases.

Original languageEnglish (US)
Article numbereaax0064
JournalScience Advances
Volume5
Issue number8
DOIs
StatePublished - Aug 21 2019

Fingerprint

viruses
genes
delivery
proteins
bacteriophages
biotin
pathogens
infectious diseases
medicine
payloads
mice
therapy
vehicles
deoxyribonucleic acid
platforms
assembly
molecules

ASJC Scopus subject areas

  • General
  • Physics and Astronomy (miscellaneous)

Cite this

A prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells. / Zhu, Jingen; Tao, Pan; Mahalingam, Marthandan; Sha, Jian; Kilgore, Paul; Chopra, Ashok; Rao, Venigalla.

In: Science Advances, Vol. 5, No. 8, eaax0064, 21.08.2019.

Research output: Contribution to journalArticle

Zhu, Jingen ; Tao, Pan ; Mahalingam, Marthandan ; Sha, Jian ; Kilgore, Paul ; Chopra, Ashok ; Rao, Venigalla. / A prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells. In: Science Advances. 2019 ; Vol. 5, No. 8.
@article{62165c72aa734fe6b27353089109004a,
title = "A prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells",
abstract = "Development of safe and efficient nanoscale vehicles that can deliver large molecular cargos into human cells could transform future human therapies and personalized medicine. Here, we design a hybrid viral vector composed of a prokaryotic virus (bacteriophage T4) and a eukaryotic virus [adeno-associated virus (AAV)]. The small 25-nm AAV is attached to the large 120 nm × 86 nm T4 head through avidin-biotin cross-bridges using the phage decoration proteins Soc and Hoc. AAV “piggy-backed” on T4 capsid, by virtue of its natural ability to enter human cells acted as an efficient “driver,” delivering the largest payloads of foreign DNA (up to 170 kb) and protein (up to 1025 molecules) reported to date, and elicited robust immune responses in mice against flu and plague pathogens and conferred complete protection against lethal pneumonic plague challenge. The T4-AAV represents a unique platform for assembly of natural building blocks into potential therapeutics against genetic and infectious diseases.",
author = "Jingen Zhu and Pan Tao and Marthandan Mahalingam and Jian Sha and Paul Kilgore and Ashok Chopra and Venigalla Rao",
year = "2019",
month = "8",
day = "21",
doi = "10.1126/sciadv.aax0064",
language = "English (US)",
volume = "5",
journal = "Indian Journal of Pure and Applied Physics",
issn = "0019-5596",
publisher = "National Institute of Science Communication and Information Resources (NISCAIR)",
number = "8",

}

TY - JOUR

T1 - A prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells

AU - Zhu, Jingen

AU - Tao, Pan

AU - Mahalingam, Marthandan

AU - Sha, Jian

AU - Kilgore, Paul

AU - Chopra, Ashok

AU - Rao, Venigalla

PY - 2019/8/21

Y1 - 2019/8/21

N2 - Development of safe and efficient nanoscale vehicles that can deliver large molecular cargos into human cells could transform future human therapies and personalized medicine. Here, we design a hybrid viral vector composed of a prokaryotic virus (bacteriophage T4) and a eukaryotic virus [adeno-associated virus (AAV)]. The small 25-nm AAV is attached to the large 120 nm × 86 nm T4 head through avidin-biotin cross-bridges using the phage decoration proteins Soc and Hoc. AAV “piggy-backed” on T4 capsid, by virtue of its natural ability to enter human cells acted as an efficient “driver,” delivering the largest payloads of foreign DNA (up to 170 kb) and protein (up to 1025 molecules) reported to date, and elicited robust immune responses in mice against flu and plague pathogens and conferred complete protection against lethal pneumonic plague challenge. The T4-AAV represents a unique platform for assembly of natural building blocks into potential therapeutics against genetic and infectious diseases.

AB - Development of safe and efficient nanoscale vehicles that can deliver large molecular cargos into human cells could transform future human therapies and personalized medicine. Here, we design a hybrid viral vector composed of a prokaryotic virus (bacteriophage T4) and a eukaryotic virus [adeno-associated virus (AAV)]. The small 25-nm AAV is attached to the large 120 nm × 86 nm T4 head through avidin-biotin cross-bridges using the phage decoration proteins Soc and Hoc. AAV “piggy-backed” on T4 capsid, by virtue of its natural ability to enter human cells acted as an efficient “driver,” delivering the largest payloads of foreign DNA (up to 170 kb) and protein (up to 1025 molecules) reported to date, and elicited robust immune responses in mice against flu and plague pathogens and conferred complete protection against lethal pneumonic plague challenge. The T4-AAV represents a unique platform for assembly of natural building blocks into potential therapeutics against genetic and infectious diseases.

UR - http://www.scopus.com/inward/record.url?scp=85071272529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071272529&partnerID=8YFLogxK

U2 - 10.1126/sciadv.aax0064

DO - 10.1126/sciadv.aax0064

M3 - Article

VL - 5

JO - Indian Journal of Pure and Applied Physics

JF - Indian Journal of Pure and Applied Physics

SN - 0019-5596

IS - 8

M1 - eaax0064

ER -